For research and laboratory use only. Not for human or animal consumption. Not intended for diagnostic, therapeutic, or clinical use.
Thymosin Alpha-1
Thymosin Alpha-1 from Primeva Labs is offered strictly for research use only. Each order includes batch-specific CoA documentation, quality verification, and secure online ordering. Not for human or animal consumption.
Primeva Labs supplies materials strictly for laboratory and research use. Create a complimentary research account to view current pricing, availability, and ordering.
By creating an account you confirm you are 21+, agree to the Terms & Research-Use Disclaimer, and acknowledge these products are sold strictly for research use — not for human or animal consumption.
What Is Thymosin Alpha-1?
Thymosin Alpha-1 is a 28-amino-acid peptide derived from the thymus, studied extensively for immune-modulation and T-cell signaling.
- 28-amino-acid thymic peptide (fragment of prothymosin alpha)
- Studied for immune modulation and T-cell maturation
- One of the most clinically characterized immunomodulatory peptides
- Supplied strictly as a research-grade reference material
Research Applications
Immune-modulation research
Studied for effects on T-cell differentiation and immune signaling.
Antiviral-response models
Examined for enhancement of antiviral immune responses in research.
Dendritic-cell studies
Investigated for activation of dendritic cells and innate signaling.
Vaccine-adjuvant research
Explored as an immune-response modifier in adjuvant studies.
Proposed Mechanisms
TLR signaling
Studied for modulation of toll-like-receptor pathways on immune cells.
T-cell maturation
Associated with promotion of T-cell differentiation and function.
Cytokine modulation
Investigated for influence on Th1-type cytokine signaling.
Dendritic-cell activation
Examined for activation of antigen-presenting dendritic cells.
Mechanisms described above are drawn from preclinical (cell and animal) research and, where noted, early clinical literature. They are provided for educational context and should not be read as clinical or therapeutic claims.
